Manuscripts and Publications

2023
Baugh AD, Acho M, Arhin A, Barjaktarevic I, Couper D, Criner G, Han ML, Hansel N, Krishnan J, Malcolm K et al..  2023.  African American race is associated with worse sleep quality in heavy smokers.. J Clin Sleep Med. 19(8):1523-1532.
Sowho MO, Koch AL, Putcha N, Woo H, Gassett A, Paulin LM, Koehler K, R Barr G, Comellas AP, Cooper CB et al..  2023.  Ambient Air Pollution Exposure and Sleep Quality in COPD.. Chronic Obstr Pulm Dis. 10(1):102-111.
Weiss JR, Serdenes R, Madtha U, Zhao H, Kim V, Lopez-Pastrana J, Eakin MN, O'Toole J, Cooper CB, Woodruff P et al..  2023.  Association Among Chronic Obstructive Pulmonary Disease Severity, Exacerbation Risk, and Anxiety and Depression Symptoms in the SPIROMICS Cohort.. J Acad Consult Liaison Psychiatry. 64(1):45-57.
Rous JS, Lees PSJ, Koehler K, Buckley JP, Quirós-Alcalá L, Han MK, Hoffman EA, Labaki W, R Barr G, Peters SP et al..  2023.  Association of Occupational Exposures and Chronic Obstructive Pulmonary Disease Morbidity.. J Occup Environ Med. 65(7):e443-e452.
Althof ZW, Gerard SE, Eskandari A, Galizia MS, Hoffman EA, Reinhardt JM.  2023.  Attention U-net for automated pulmonary fissure integrity analysis in lung computed tomography images. Sci Rep. 13(1):14135.
DiLillo KM, Norman KC, Freeman CM, Christenson SA, Alexis NE, Anderson WH, Barjaktarevic IZ, R Barr G, Comellas AP, Bleecker ER et al..  2023.  A blood and bronchoalveolar lavage protein signature of rapid FEV decline in smoking-associated COPD.. Sci Rep. 13(1):8228.
Fortis S, Quibrera PM, Comellas AP, Bhatt SP, Tashkin DP, Hoffman EA, Criner GJ, Han MK, R Barr G, Arjomandi M et al..  2023.  Bronchodilator Responsiveness in Tobacco-Exposed People With or Without COPD.. Chest. 163(3):502-514.
Arjomandi M, Zeng S, Chen J, Bhatt SP, Abtin F, Barjaktarevic I, R Barr G, Bleecker ER, Buhr RG, Criner GJ et al..  2023.  Changes in Lung Volumes with Spirometric Disease Progression in COPD.. Chronic Obstr Pulm Dis. 10(3):270-285.
W LeMaster B, P Quibrera M, Couper D, Tashkin DP, Bleecker ER, Doerschuk CM, Ortega VE, Cooper C, Han MK, Woodruff PG et al..  2023.  Clinical Implications of Low Absolute Blood Eosinophil Count in the SPIROMICS COPD Cohort.. Chest. 163(3):515-528.
Van Buren E, Radicioni G, Lester S, O'Neal WK, Dang H, Kasela S, Garudadri S, Curtis JL, Han MK, Krishnan JA et al..  2023.  Genetic regulators of sputum mucin concentration and their associations with COPD phenotypes.. PLoS Genet. 19(6):e1010445.
Izquierdo M, Marion CR, Genese F, Newell JD, O'Neal WK, Li X, Hawkins GA, Barjaktarevic I, R Barr G, Christenson S et al..  2023.  Impact of Bronchiectasis on COPD Severity and Alpha-1 Antitrypsin Deficiency as a Risk Factor in Individuals with a Heavy Smoking History.. Chronic Obstr Pulm Dis. 10(3):199-210.
Barjaktarevic I, Cooper CB, Shing T, Buhr RG, Hoffman EA, Woodruff PG, M Drummond B, Kanner RE, Han MK, Hansel NN et al..  2023.  Impact of Marijuana Smoking on COPD Progression in a Cohort of Middle-Aged and Older Persons.. Chronic Obstr Pulm Dis. 10(3):234-247.
Hill AC, Guo C, Litkowski EM, Manichaikul AW, Yu B, Konigsberg IR, Gorbet BA, Lange LA, Pratte KA, Kechris KJ et al..  2023.  Large scale proteomic studies create novel privacy considerations.. Sci Rep. 13(1):9254.
McKleroy W, Shing T, Anderson WH, Arjomandi M, Awan HAnees, Barjaktarevic I, R Barr G, Bleecker ER, Boscardin J, Bowler RP et al..  2023.  Longitudinal Follow-Up of Participants With Tobacco Exposure and Preserved Spirometry.. JAMA. 330(5):442-453.
Wang JM, Labaki WW, Murray S, Martinez FJ, Curtis JL, Hoffman EA, Ram S, Bell AJ, Galbán CJ, Han MK et al..  2023.  Machine learning for screening of at-risk, mild and moderate COPD patients at risk of FEV decline: results from COPDGene and SPIROMICS.. Front Physiol. 14:1144192.
Chaudhary MFA, Hoffman EA, Guo J, Comellas AP, Newell JD, Nagpal P, Fortis S, Christensen GE, Gerard SE, Pan Y et al..  2023.  Predicting severe chronic obstructive pulmonary disease exacerbations using quantitative CT: a retrospective model development and external validation study.. Lancet Digit Health. 5(2):e83-e92.
Esther CR, O'Neal WK, Alexis NE, Koch AL, Cooper CB, Barjaktarevic I, Raffield LM, Bowler RP, Comellas AP, Peters SP et al..  2023.  Prolonged, physiologically relevant nicotine concentrations in the airways of smokers.. Am J Physiol Lung Cell Mol Physiol. 324(1):L32-L37.
Angelini ED, Yang J, Balte PP, Hoffman EA, Manichaikul AW, Sun Y, Shen W, Austin JHM, Allen NB, Bleecker ER et al..  2023.  Pulmonary emphysema subtypes defined by unsupervised machine learning on CT scans.. Thorax.
LaFon DC, Woo H, Fedarko N, Azar A, Hill H, Tebo AE, Martins TB, Han MK, Krishnan JA, Ortega VE et al..  2023.  Reduced quantity and function of pneumococcal antibodies are associated with exacerbations of COPD in SPIROMICS.. Clin Immunol. 250:109324.
Motahari A, R Barr G, Han MK, Anderson WH, Barjaktarevic I, Bleecker ER, Comellas AP, Cooper CB, Couper DJ, Hansel NN et al..  2023.  Repeatability of Pulmonary Quantitative Computed Tomography Measurements in Chronic Obstructive Pulmonary Disease.. Am J Respir Crit Care Med. 208(6):657-665.
2022
Belz DC, Woo H, Putcha N, Paulin LM, Koehler K, Fawzy A, Alexis NE, R Barr G, Comellas AP, Cooper CB et al..  2022.  Ambient ozone effects on respiratory outcomes among smokers modified by neighborhood poverty: An analysis of SPIROMICS AIR.. Sci Total Environ. 829:154694.
Tejwani V, Woo H, Liu C, Tillery AK, Gassett AJ, Kanner RE, Hoffman EA, Martinez FJ, Woodruff PG, R Barr G et al..  2022.  Black carbon content in airway macrophages is associated with increased severe exacerbations and worse COPD morbidity in SPIROMICS.. Respir Res. 23(1):310.
Krishnan JK, Ancy KM, Oromendia C, Hoffman KL, Easthausen I, Leidy NK, Han MK, Bowler RP, Christenson SA, Couper DJ et al..  2022.  Characterizing COPD Symptom Variability in the Stable State Utilizing the Evaluating Respiratory Symptoms in COPD Instrument.. Chronic Obstr Pulm Dis. 9(2):195-208.
Iyer AS, Parekh TM, O'Toole J, Bhatt SP, Eakin MN, Krishnan JA, Yohannes AM, Woodruff PG, Cooper CB, Kanner RE et al..  2022.  Clinically Significant and Comorbid Anxiety and Depression Symptoms Predict Severe Respiratory Exacerbations in Smokers: A Analysis of the COPDGene and SPIROMICS Cohorts.. Ann Am Thorac Soc. 19(1):143-146.
O'Toole J, Woo H, Putcha N, Cooper CB, Woodruff P, Kanner RE, Paine R, Bowler RP, Comellas A, Hoth KF et al..  2022.  Comparative Impact of Depressive Symptoms and FEV% on Chronic Obstructive Pulmonary Disease.. Ann Am Thorac Soc. 19(2):171-178.

Pages